AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Multiple Myeloma Hub
Which patients might benefit the most from isatuximab-based combinations in the relapsed setting?
Oct 2, 2022
Roman Hájek, from the University of Ostrava, discusses the benefits of isatuximab-based combinations in treating relapsed multiple myeloma patients refractory to lenalidomide-based therapy. The focus is on the efficacy of isatuximab with carfilzomib and dexamethasone, highlighting the role of immunomodulatory agents in improving outcomes.
03:03
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Isatuximab in combination with carfilzomib and dexamethasone is highly beneficial for multiple myeloma patients refractory to lenalidomide-based therapy.
- Immunomodulatory agents like Isatuximab offer significant advancements in multiple myeloma treatment efficacy, particularly for patients refractory to lenalidomide-based regimens.
Deep dives
Role of Isatuximab in Combination Therapy
Isatuximab, an anti-CD38 monoclonal antibody, has shown significant benefits in combination therapy for multiple myeloma patients. In particular, when combined with carfilzomib and dexamethasone, it demonstrated a substantial advantage over other treatments. The efficacy of this combination was especially highlighted in patients who were refractory to lenalidomide-based therapy, offering a robust and potent treatment option.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode